Gardasil
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
208 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Papillomavirus infections | D030361 | — | — | 3 | 9 | 29 | 18 | 17 | 76 |
| Uterine cervical neoplasms | D002583 | HP_0030159 | — | 4 | 6 | 18 | 8 | 10 | 44 |
| Papilloma | D010212 | — | — | 5 | 2 | 8 | 5 | 11 | 30 |
| Papillomaviridae | D027383 | — | — | 3 | 2 | 2 | 2 | 5 | 13 |
| Infections | D007239 | EFO_0000544 | — | — | 3 | 3 | 3 | 4 | 13 |
| Alphapapillomavirus | D052685 | — | — | 1 | 1 | 2 | 3 | 4 | 11 |
| Warts | D014860 | — | B07 | 1 | 2 | 6 | 1 | 2 | 10 |
| Uterine cervical dysplasia | D002578 | EFO_1000910 | N87 | 1 | 2 | 2 | 3 | 1 | 9 |
| Neoplasms | D009369 | — | C80 | — | 4 | 2 | 3 | — | 8 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 1 | 1 | 2 | 3 | 8 |
Show 22 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Condylomata acuminata | D003218 | EFO_0007147 | A63.0 | 2 | 3 | 22 | — | 6 | 32 |
| Vaginal neoplasms | D014625 | — | C52 | 1 | 2 | 7 | — | 1 | 11 |
| Vulvar neoplasms | D014846 | — | C51 | 1 | 2 | 7 | — | 1 | 11 |
| Recurrence | D012008 | — | — | 1 | 1 | 2 | — | 2 | 6 |
| Respiratory tract infections | D012141 | — | J06.9 | 1 | — | 2 | — | 1 | 4 |
| Anus neoplasms | D001005 | EFO_0003835 | C21 | — | 2 | 1 | — | 1 | 4 |
| Communicable diseases | D003141 | — | — | — | 1 | 2 | — | — | 3 |
| Transplantation | D014180 | — | — | — | 1 | 2 | — | — | 3 |
| Meningococcal infections | D008589 | EFO_0004249 | A39 | — | 1 | 1 | — | — | 2 |
| Squamous intraepithelial lesions of the cervix | D065310 | — | — | — | 1 | 1 | — | — | 2 |
Show 16 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Precancerous conditions | D011230 | — | — | 1 | 2 | — | — | — | 3 |
| Sexually transmitted diseases | D012749 | — | A50-A64 | — | 1 | — | — | 1 | 2 |
| Disease | D004194 | EFO_0000408 | R69 | 1 | 1 | — | — | — | 2 |
| Female genital diseases | D005831 | EFO_0009549 | N85 | — | 1 | — | — | — | 1 |
| Genital diseases | D000091662 | — | — | — | 1 | — | — | — | 1 |
| Prostatic intraepithelial neoplasia | D019048 | — | N42.31 | — | 1 | — | — | — | 1 |
| Lymphopenia | D008231 | HP_0001888 | D72.810 | — | 1 | — | — | — | 1 |
| Idiopathic cd4-positive t-lymphocytopenia | D018344 | EFO_0007322 | — | — | 1 | — | — | — | 1 |
| Carcinoma in situ | D002278 | — | D09.9 | — | 1 | — | — | — | 1 |
| Squamous cell carcinoma | D002294 | — | — | — | 1 | — | — | — | 1 |
Show 12 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Stem cell transplantation | D033581 | — | — | 1 | — | — | — | — | 1 |
| Vaccine immunogenicity | D000071497 | — | — | 1 | — | — | — | — | 1 |
| Adolescent development | D041923 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hiv seropositivity | D006679 | — | — | — | — | — | — | 2 | 2 |
| Spontaneous abortion | D000022 | EFO_1001255 | O00.1 | — | — | — | — | 1 | 1 |
| Viral sexually transmitted diseases | D015229 | — | — | — | — | — | — | 1 | 1 |
| Vaccinia | D014615 | — | — | — | — | — | — | 1 | 1 |
| Oropharyngeal neoplasms | D009959 | — | — | — | — | — | — | 1 | 1 |
| Health behavior | D015438 | — | — | — | — | — | — | 1 | 1 |
| Behavior | D001519 | GO_0007610 | — | — | — | — | — | 1 | 1 |
| Psychological distance | D012929 | — | — | — | — | — | — | 1 | 1 |
| Emergencies | D004630 | — | — | — | — | — | — | 1 | 1 |
| Postpartum period | D049590 | — | — | — | — | — | — | 1 | 1 |
Show 2 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | — |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Gardasil – Merck & Co
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use